Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	1,170	1,188	1,093	901	791	647	Upgrade
Revenue Growth (YoY)	4.09%	8.69%	21.31%	13.91%	22.26%	-17.58%	Upgrade
Cost of Revenue	215	209	186	151	127	92	Upgrade
Gross Profit	955	979	907	750	664	555	Upgrade
Selling, General & Admin	577	588	543	469	425	427	Upgrade
Research & Development	97	103	106	74	52	40	Upgrade
Other Operating Expenses	-4	-4	-2	-8	-	-	Upgrade
Operating Expenses	670	687	647	535	477	467	Upgrade
Operating Income	285	292	260	215	187	88	Upgrade
Interest Expense	-34	-31	-30	-27	-18	-17	Upgrade
Interest & Investment Income	19	22	43	19	1	7	Upgrade
Other Non Operating Income (Expenses)	-2	-2	-1	1	3	-	Upgrade
EBT Excluding Unusual Items	268	281	272	208	173	78	Upgrade
Merger & Restructuring Charges	-65	-65	-22	-	1	-11	Upgrade
Gain (Loss) on Sale of Investments	-9	-9	-	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	20	-	Upgrade
Asset Writedown	-35	-35	-	-	-	-	Upgrade
Legal Settlements	-201	-200	-247	-296	-14	-235	Upgrade
Other Unusual Items	-16	-16	-3	-	-2	-5	Upgrade
Pretax Income	-57	-43	1	-88	190	-173	Upgrade
Income Tax Expense	5	5	-1	-44	-15	-25	Upgrade
Net Income	-62	-48	2	-44	205	-148	Upgrade
Net Income to Common	-62	-48	2	-44	205	-148	Upgrade
Shares Outstanding (Basic)	129	132	137	139	146	147	Upgrade
Shares Outstanding (Diluted)	129	132	142	139	152	147	Upgrade
Shares Change (YoY)	-8.16%	-6.69%	2.01%	-8.52%	3.66%	-2.98%	Upgrade
EPS (Basic)	-0.48	-0.36	0.01	-0.32	1.41	-1.01	Upgrade
EPS (Diluted)	-0.48	-0.36	0.01	-0.32	1.35	-1.01	Upgrade
Free Cash Flow	103	-6	-323	-9	349	-197	Upgrade
Free Cash Flow Per Share	0.80	-0.04	-2.28	-0.07	2.30	-1.34	Upgrade
Gross Margin	81.62%	82.41%	82.98%	83.24%	83.94%	85.78%	Upgrade
Operating Margin	24.36%	24.58%	23.79%	23.86%	23.64%	13.60%	Upgrade
Profit Margin	-5.30%	-4.04%	0.18%	-4.88%	25.92%	-22.88%	Upgrade
Free Cash Flow Margin	8.80%	-0.51%	-29.55%	-1.00%	44.12%	-30.45%	Upgrade
EBITDA	309	316	277	228	199	101	Upgrade
EBITDA Margin	26.41%	26.60%	25.34%	25.30%	25.16%	15.61%	Upgrade
D&A For EBITDA	24	24	17	13	12	13	Upgrade
EBIT	285	292	260	215	187	88	Upgrade
EBIT Margin	24.36%	24.58%	23.79%	23.86%	23.64%	13.60%	Upgrade
Advertising Expenses	-	-	-	52	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.